Efficacy of intranasal dexmedetomidine versus oral midazolam for paediatric premedication

Lakshmi Kumar, Ajay Kumar, Ramkumar Panikkaveetil, Bindu K Vasu, Sunil Rajan, Suresh G Nair, Lakshmi Kumar, Ajay Kumar, Ramkumar Panikkaveetil, Bindu K Vasu, Sunil Rajan, Suresh G Nair

Abstract

Background and aims: Premedication is an integral component of paediatric anaesthesia which, when optimal, allows comfortable separation of the child from the parent for induction and conduct of anaesthesia. Midazolam has been accepted as a safe and effective oral premedicant. Dexmedetomidine is a selective alpha-2 agonist with sedative and analgesic effects, which is effective through the transmucosal route. We compared the efficacy and safety of standard premedication with oral midazolam versus intranasal dexmedetomidine as premedication in children undergoing elective lower abdominal surgery.

Methods: This was a prospective randomised double-blinded trial comparing the effects of premedication with 0.5 mg/kg oral midazolam versus 1 μg/kg intranasal dexmedetomidine in children between 2 and 12 years undergoing abdominal surgery. Sedation scores at separation and induction were the primary outcome measures. Behaviour scores and haemodynamic changes were secondary outcomes. Student's t-test and Chi-square were used for analysis of the variables.

Results: Sedation scores were superior in Group B (dexmedetomidine) than Group A (midazolam) at separation and induction (P < 0.001). The behaviour scores at separation, induction and wake up scores at extubation were similar between the two groups. The heart rate and blood pressure showed significant differences at 15, 30 and 45 min in Group B but did not require pharmacological intervention for correction.

Conclusion: Intranasal dexmedetomidine at a dose of 1 μg/kg produced superior sedation scores at separation and induction but normal behavioural scores in comparison to oral midazolam in paediatric patients.

Keywords: Intranasal dexmedetomidine; oral midazolam; paediatric premedication.

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Distribution of mean arterial pressure
Figure 2
Figure 2
Distribution of mean heart rate
Figure 3
Figure 3
Distribution of sedation and behaviour scores

References

    1. Shabbir A, Bhat SS, Sundeep Hegde K, Salman M. Comparison of oral midazolam and triclofos in conscious sedation of uncooperative children. J Clin Pediatr Dent. 2011;36:189–96.
    1. Kazak Z, Sezer GB, Yilmaz AA, Ates Y. Premedication with oral midazolam with or without parental presence. Eur J Anaesthesiol. 2010;27:347–52.
    1. Radhika KP, Sreejit MS, Ramadas KT. Efficacy of midazolam as oral premedication in children in comparison to triclofos sodium. Indian J Anaesth. 2016;60:415–9.
    1. Dewhirst E, Fedel G, Raman V, Rice J, Barry N, Jatana KR, et al. Pain management following myringotomy and tube placement: Intranasal dexmedetomidine versus intranasal fentanyl. Int J Pediatr Otorhinolaryngol. 2014;78:1090–4.
    1. Yuen VM, Hui TW, Irwin MG, Yuen MK. A comparison of intranasal dexmedetomidine and oral midazolam for premedication in pediatric anesthesia: A double-blinded randomized controlled trial. Anesth Analg. 2008;106:1715–21.
    1. Akin A, Bayram A, Esmaoglu A, Tosun Z, Aksu R, Altuntas R, et al. Dexmedetomidine vs midazolam for premedication of pediatric patients undergoing anesthesia. Paediatr Anaesth. 2012;22:871–6.
    1. Grewal A. Dexmedetomidine: New avenues. J Anaesthesiol Clin Pharmacol. 2011;27:297–302.
    1. Peng K, Wu SR, Ji FH, Li J. Premedication with dexmedetomidine in pediatric patients: A systematic review and meta-analysis. Clinics (Sao Paulo) 2014;69:777–86.
    1. Chaudhary S, Jindal R, Girotra G, Salhotra R, Rautela RS, Sethi AK. Is midazolam superior to triclofos and hydroxyzine as premedicant in children? J Anaesthesiol Clin Pharmacol. 2014;30:53–8.
    1. Parameswari A, Maheedar G, Vakamudi M. Sedative and Anxiolytic effects of Midazolam and triclofos oral premedication in children undergoing elective surgery. A comparison. J Anaesthesiol Clin Pharmacol. 2010;26:340–4.
    1. Yuen VM, Hui TW, Irwin MG, Yao TJ, Wong GL, Yuen MK. Optimal timing for the administration of intranasal dexmedetomidine for premedication in children. Anaesthesia. 2010;65:922–9.
    1. Yuen VM, Irwin MG, Hui TW, Yuen MK, Lee LH. A double-blind, crossover assessment of the sedative and analgesic effects of intranasal dexmedetomidine. Anesth Analg. 2007;105:374–80.
    1. Ali AR, El Ghoneimy MN. Dexmedetomidine versus fentanyl as adjuvant to propofol: Comparative study in children undergoing extracorporeal shock wave lithotripsy. Eur J Anaesthesiol. 2010;27:1058–64.
    1. Jayaraman L, Sinha A, Punhani D. A comparative study to evaluate the effect of intranasal dexmedetomidine versus oral alprazolam as a premedication agent in morbidly obese patients undergoing bariatric surgery. J Anaesthesiol Clin Pharmacol. 2013;29:179–82.
    1. Schmidt AP, Valinetti EA, Bandeira D, Bertacchi MF, Simões CM, Auler JO., Jr Effects of preanesthetic administration of midazolam, clonidine, or dexmedetomidine on postoperative pain and anxiety in children. Paediatr Anaesth. 2007;17:667–74.
    1. Mariappan R, Ashokkumar H, Kuppuswamy B. Comparing the effects of oral clonidine premedication with intraoperative dexmedetomidine infusion on anesthetic requirement and recovery from anesthesia in patients undergoing major spine surgery. J Neurosurg Anesthesiol. 2014;26:192–7.
    1. Rajalakshmi J, Lokesh K. A study to evaluate the effects of intranasal dexmedetomidine as a premedicant in paediatric patients undergoing cardiac surgeries. Egypt J Cardiothorac Anesth. 2015;9:17–22.
    1. Faritus SZ, Khazaee-Koohpar M, Ziyaeifard M, Mehrabanian MJ. Oral dexmedetomidine versus midazolam as anesthetic premedication in children undergoing congenital heart surgery. Anesth Pain Med. 2015;5:e25032.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe